Melissa officinalis extract inhibits attachment of herpes simplex virus in vitro

Chemotherapy

Volumn 58, Issue 1, 2012, Pages 70-77

  Astani, Akram ^a,b   Reichling, Jrgen ^a   Schnitzler, Paul ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antiviral activity; Caffeic acid; Herpes simplex virus type 1; Melissa extract; p Coumaric acid; Rosmarinic acid

Indexed keywords

CAFFEIC ACID; MELISSA OFFICINALIS EXTRACT; PARA COUMARIC ACID; PROTEIN ICP0; ROSMARINIC ACID; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HERPES SIMPLEX VIRUS 1; IN VITRO STUDY; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS INHIBITION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CINNAMATES; DEPSIDES; HERPESVIRUS 1, HUMAN; HUMANS; MELISSA; OILS, VOLATILE; PLANT EXTRACTS; VIRAL PLAQUE ASSAY; VIRAL PROTEINS; VIRUS INTERNALIZATION;

EID: 84857491261     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000335590     Document Type: Article

References (42)

1. Whitley RJ, Roizman B: Herpes simplex virus infections. Lancet 2001; 357: 1513-1518.
2. Whitley RJ, Levin M, Barton N, Hershey BJ, Davis G, Keeney RE, Welchel J, Diethelm AG, Kartus P, Soong SJ: Infections caused by herpes simplex in the immunocompromised host: Natural history and topical acyclovir therapy. J Infect Dis 1984; 150: 323-329.
3. Brady RC, Bernstein DI: Treatment of herpes simplex virus infections. Antiviral Res 2004; 61: 73-81.
4. De Clercq E: Antiviral drugs in current clinical use. J Clin Virol 2004; 30: 115-133.
5. Efferth T: Natural products pave their way in cancer therapy. Cancer Biol Ther 2009; 8: 1869-1870.
6. Wölbling RH, Leonhardt K: Local therapy of herpes simplex with dried extract from Melissa officinalis Phytomedicine 1994; 1: 25-31.
7. Saller R, Buechi S, Meyrat R, Schmidhauser C: Combined herbal preparation for topical treatment of herpes labialis. Forsch Komplementmed 2001; 8: 373-382.
8. Bozin B, Mimica-Dukic N, Samojlik I, Jovin E: Antimicrobial and antioxidant properties of rosemary and sage ( Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J Agric Food Chem 2007; 55: 7879-7885.
9. Moreno S, Scheyer T, Romano CS, Vojnov AA: Antioxidant and antimicrobial activities of rosemary extracts linked to their polyphenol composition. Free Radic Res 2006; 40: 223-231.
10. Fu Y, Zu Y, Chen L, Efferth T, Liang H, Liu Z, Liu W: Investigation of antibacterial activity of rosemary essential oil against Propionibacterium acnes with atomic force microscopy. Planta Med 2007; 73: 1275-1280.
11. Vanden Berghe DA, Vlietinck AJ, Van Hoof L: Plant products as potential antiviral agents. Bull Inst Pasteur 1986; 84: 101-147.
12. Koytchev R, Alken RG, Dundarov S: Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis. Phytomedicine 1999; 6: 225-230.
13. Gaby AR: Natural remedies for herpes simplex. Altern Med Rev 2006; 11: 93-101.
14. Debiaggi M, Tateo F, Cereda PM, Pagani L, Landini P, Romero E: Effect of a Rosmarinus officinalis L. fraction on uninfected and herpes simplex virus infected cells. Ann Microbiol Enzimol 1989; 39: 181-194.
15. Carnat P, Carnat A, Fraisse D, Lamaison J: The aromatic and polyphenolic composition of lemon balm ( Melissa officinalis L. subsp. officinalis ) tea. Pharma Acta Helv 1998; 72: 301-305.
16. Nolkemper S, Reichling J, Stintzing FC, Carle R, Schnitzler P: Antiviral effect of aqueous extracts from species of the Lamiaceae family against herpes simplex virus type 1 and type 2 in vitro. Planta Med 2006; 72: 1378-1382.
17. Geuenich S, Goffinet C, Venzke S, Nolkemper S, Baumann I, Plinkert P, Reichling J, Keppler OT: Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion density. Retrovirology 2008; 5: 27.
18. Oruga J, Vlase L, Toiu A, Benedec D, Duda M: Evaluation of phenolic acid derivatives and essential oil content in some Melissa officinalis L. varieties. Farmacia 2008; 58: 764-769.
19. Fecka I, Turek S: Determination of water-soluble polyphenolic compounds in commercial herbal teas from Lamiaceae: Peppermint, Melissa, and sage. J Agric Food Chem 2007; 55: 10908-10917.
20. Agata I, Kusakabe H, Hatano T, Nishibe S, Okuda T: Melitric acids A and B, new trimeric caffeic acid derivatives from Melissa officinalis Chem Pharm Bull 1993; 41: 1608-1611.
21. Patora J, Klinek B: Flavonoids from lemon balm ( Melissa officinalis L., Lamiaceae). Acta Pol Pharm 2002; 59: 39-143.
22. Schnitzler P, Koch C, Reichling J: Susceptibility of drug-resistant clinical herpes simplex virus type 1 strains to essential oils of ginger, thyme, hyssop, and sandalwood. Antimicrob Agents Chemother 2007; 51: 1859-1862.
23. Söderberg T, Johannson A, Gref R: Toxic effects of some conifer resin acids and tea tree oil on human epithelial and fibroblast cells. Toxicology 1996; 107: 99-109.
24. Cheng HY, Lin CC, Lin TC: Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn. Antiviral Res 2002; 55: 447-455.
25. Su CT, Hsu JT, Hsieh HP, Lin PH, Chen TC, Kao CL, Lee CN, Chang SY: Anti-HSV activity of digitoxin and its possible mechanisms. Antiviral Res 2008; 79: 62-70.
26. Cheng HY, Lin TC, Yang CM, Wang KC, Lin LT, Lin CC: Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage replication of herpes simplex virus type 2 in vitro. J Antimicrob Chemother 2004; 53: 577-583.
27. Khan MT, Ather A, Thompson K, Gambari R: Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res 2005; 67: 107-119.
28. Akhtar J, Shukla D: Viral entry mechanisms: Cellular and viral mediators of herpes simplex virus entry. FEBS J 2009; 276: 7228-7236.
29. Halle W, Göres E: Prediction of LD 50 values by cell culture. Pharmazie 1987; 42: 245-248.
30. Mazzanti G, Battinelli L, Pompeo C, Serrilli AM, Rossi R, Sauzullo I, Mengoni F, Vullo V: Inhibitory activity of Melissa officinalis L. extract on herpes simplex virus type 2 replication. Nat Prod Res 2008; 22: 1433-1440.
31. Chiang LC, Chiang W, Chang MY, Ng LT, Lin CC: Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res 2002; 55: 53-62.
32. Schneider S, Reichling J, Stintzing FC, Messerschmidt S, Meyer U, Schnitzler P: Antiherpetic properties of hydroalcoholic extracts and pressed juice from Echinacea pallida Planta Med 2010; 76: 265-272.
33. Gescher K, Hensel A, Hafezi W, Derksen A, Kühn J: Oligomeric proanthocyanidins from Rumex acetosa L. inhibit the attachment of herpes simplex virus type-1. Antiviral Res 2011; 89: 9-18.
34. Gescher K, Kühn J, Hafezi W, Louis A, Derksen A, Deters A, Lorentzen E, Hensel A: Inhibition of viral adsorption and penetration by an aqueous extract from Rhododendron ferrugineum L. as antiviral principle against herpes simplex virus type-1. Fitoterapia 2011; 82: 408-413.
35. Bandyopadhyay SS, Heidary Navid M, Ghosh T, Schnitzler P, Ray B: Structural features and in vitro antiviral activities of sulfated polysaccharides from Sphacelaria indica. Phytochemistry 2011; 72: 276-283.
36. Romanutti C, Bruttomesso AC, Castilla V, Galagovsky LR, Wachsman MB: Anti-adenovirus activity of epiandrosterone and dehydroepiandrosterone derivatives. Chemotherapy 2010; 56: 158-165.
37. Esimone CO, Grunwald T, Nworu CS, Kuate S, Proksch P, Überla K: Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach. Chemotherapy 2009; 55: 119-126.
38. Efferth T, Koch E: Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr Drug Targets 2011; 12: 122-132.
39. Astani A, Reichling J, Schnitzler P: Screening for antiviral activities of isolated compounds from essential oils. Evid Based Complement Alternat Med DOI: 10.1093/ecam/ nep187.
40. Cos P, Vlietinck AJ, Berghe DV, Maes L: Anti-infective potential of natural products: How to develop a stronger in vitro 'proof-ofconcept'. J Ethnopharmacol 2006; 106: 290-302.
41. Bergefall K, Trybala E, Johansson M, Uyama T, Naito S, Yamada S, Kitagawa H, Sugahara K, Bergstrom T: Chondroitin sulfate characterized by the E-disaccharide unit is a potent inhibitor of herpes simplex virus infectivity and provides the virus binding sites on gro2C cells. J Biol Chem 2005; 280: 32193-32199.
42. Garozzo A, Timpanaro R, Bisignano B, Furneri PM, Bisignano G, Castro A: In vitro antiviral activity of Melaleuca alternifolia essential oil. Lett Appl Microbiol 2009; 49: 806-808.